Search

Search Constraints

You searched for: Author/Creator Mukohara, Toru

Search Results

11. Pathologic method for extracting good prognosis group in triple‐negative breast cancer after neoadjuvant chemotherapy. Issue 4 (1st March 2022)

12. Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function. Issue 6 (11th May 2019)

13. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort. (June 2022)

14. Quantitative analysis of drug distribution in heterogeneous tissues using dual‐stacking capillary electrophoresis–mass spectrometry. (13th December 2022)

15. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer. Issue 6 (December 2016)

17. Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B). (August 2022)

18. Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria. Issue 6 (December 2018)

19. The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis. (August 2021)